Sculptor Capital’s Guardant Health GH Stock Holding History

Sculptor Capital’s Portfolio GH Stock Details GH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-482,574	Closed	-$26M	–	862
2022 Q3	$26M	Buy	+482,574	New	+$24.8M	0.32%	41

Other funds holding GH

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Sculptor Capital's GH Position: Q4 2022 in Review

Sculptor Capital sold out of Guardant Health (GH) in Q4 2022, closing a stake of 482,574 shares — an estimated $26M sold.

Sculptor Capital first reported a position in GH in Q3 2022 and held it in 1 quarter. The position peaked at $26M in Q3 2022. 290 funds tracked by Wall St. Rank hold GH as of Q4 2022.

Sculptor Capital reported no remaining Guardant Health position as of Q4 2022 after selling out during the quarter.
Sculptor Capital sold 482,574 Guardant Health shares in Q4 2022, an estimated $26M.
Sculptor Capital first reported a position in Guardant Health in Q3 2022 and held it in 1 quarter.
Sculptor Capital's Guardant Health position peaked at $26M in Q3 2022.
290 funds tracked by Wall St. Rank held Guardant Health as of Q4 2022.

Based on Sculptor Capital's 13F filing for Q4 2022, filed 14 Feb 2023.